BRONTUSS SF-NR (DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE) LIQUID [PORTAL PHARMACEUTICAL]

BRONTUSS SF-NR (DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE) LIQUID [PORTAL PHARMACEUTICAL]
PDF | XML

NDC 49963-381-01, 49963-381-04
Set ID 5732c79c-9717-498b-b511-f6da2dfbb867
Category HUMAN OTC DRUG LABEL
Packager Portal Pharmaceutical
Generic Name
Product Class alpha-1 Adrenergic Agonist
Product Number
Application Number PART341
  • Drug Facts

    Active ingredients
    (in each 5 mL teaspoonful)
    Dextromethorphan Hydrobromide 15 mg
    Guaifenesin 300 mg
    Phenylephrine Hydrochloride 10 mg

    Purpose

    Antitussive
    Expectorant
    Nasal Decongestant
  • Uses

    Temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies:
    • cough due to minor throat and bronchial irritation
    • helps phlegm (mucus) and thin bronchial secretions to drain bronchial tubes and make coughs more productive
    • nasal congestion
    • reduces swelling of nasal passages
  • Warnings

    Do not exceed recommended dosage.

    Do not use this product

    • if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug.  If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

    Ask a doctor before use if you have

    • a cough that lasts or is chronic such as occurs with smoking, asthma, chronic bronchitis or emphysema
    • a cough that occurs with too much phlegm (mucus)
    • heart disease
    • high blood pressure
    • thyroid disease
    • diabetes
    • trouble urinating due to an enlarged prostate gland

    Stop use and ask a doctor if

    • nervousness, dizziness, or sleeplessness occur
    • cough or nasal congestion persists for more than 1 week, tends to recur, or is accompanied by a fever, rash, or persistent headache.  A persistent cough may be a sign of a serious condition.

    If pregnant or breast-feeding, ask a health professional before use.

    Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center right away.
  • Directions

    Do not exceed recommended dosage.
    Adults and
    Children 12
    years of age
    and over:
    1 teaspoonful (5 mL)
    every 4 hours, not to
    exceed 6 doses in 24
    hours.
    Children 6 to
    under 12
    years of age:

    1/2 teaspoonful (2.5 mL)
    every 4 hours, not to
    exceed 6 doses in 24
    hours.
    Children
    under 6 years
    of age:
    Consult a doctor.



  • Other information

    • Each 5 mL teaspoonful contains 5 mg sodium.
    • Store at 59°-86° F (15°-30° C)
  • Inactive ingredients

    citric acid, glycerin, grape flavor, propylene glycol, purified water, sodium citrate, sodium saccharin, sorbitol.
  • Questions? Comments?

    Call your doctor for medical advice about side effects.  Serious side effects associated with this product may be reported to this number.
    Call (787) 832-6645.  Operation Hours: Monday - Friday, 8 A.M. to 4 P.M. Atlantic Standard Time (AST)
    portalpharmaceutical@gmail.com

    Manufactured for:
    Portal Pharmaceutical
    Mayaguez, PR  00681

    Rev. 11/11
  • Product Packaging

    The packaging below represents the labeling currently used.

    Principal display panel and side panel for 30 mL label:

    NDC 49963-381-01

    Brontuss
    SF-NR
    Liquid

    · Antitussive · Expectorant
    · Nasal Decongestant

    Each teaspoonful (5 mL) for
    oral administration contains:

    Dextromethorphan HBr....................15 mg
    Guaifenesin..................................300 mg
    Phenylephrine HCl..........................10 mg

    Grape Flavor
    Dye Free · Sugar Free · Alcohol Free

    1 oz. (30 mL)

    Tamper evident by foil seal under cap.  Do not use if
    foil seal is broken or missing.
    Supplied in a tight, light-resistant container with a child-
    resistant cap.

    Manufactured for:
    PORTAL
    Pharmaceutical
    Mayaguez, PR  00680                         Rev. 11/11

    Professional Sample:  Not For Sale

    Brontuss SF-NR Packaging


    Brontuss SF-NR Packaging



  • INGREDIENTS AND APPEARANCE
    BRONTUSS  SF-NR
    dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:49963-381
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    Dextromethorphan Hydrobromide (UNII: 9D2RTI9KYH) (Dextromethorphan - UNII:7355X3ROTS) Dextromethorphan Hydrobromide15 mg  in 5 mL
    Guaifenesin (UNII: 495W7451VQ) (Guaifenesin - UNII:495W7451VQ) Guaifenesin300 mg  in 5 mL
    Phenylephrine Hydrochloride (UNII: 04JA59TNSJ) (Phenylephrine - UNII:1WS297W6MV) Phenylephrine Hydrochloride10 mg  in 5 mL
    Inactive Ingredients
    Ingredient NameStrength
    Citric Acid Monohydrate (UNII: 2968PHW8QP)  
    Glycerin (UNII: PDC6A3C0OX)  
    Water (UNII: 059QF0KO0R)  
    Sodium Citrate (UNII: 1Q73Q2JULR)  
    Saccharin Sodium (UNII: SB8ZUX40TY)  
    Sorbitol (UNII: 506T60A25R)  
    Product Characteristics
    Color    Score    
    ShapeSize
    FlavorGRAPEImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:49963-381-0130 mL in 1 BOTTLE
    2NDC:49963-381-04118 mL in 1 BOTTLE
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalpart34112/22/2011
    Labeler - Portal Pharmaceutical (831005199)
    Registrant - Great Southern Laboratories (056139553)
    Establishment
    NameAddressID/FEIBusiness Operations
    Great Southern Laboratories056139553manufacture

Related Drugs